Peptide catestatin reduces tau tangles and improves cognition in mice
A mouse model study found that supplementation with catestatin — a peptide derived from chromogranin A — reduced tau pathology and improved performance on spatial memory tasks, though complete elimination of tau tangles was not achieved. Tau accumulation is a hallmark of Alzheimer's disease and several related neurodegenerative conditions.
- Catestatin is derived from chromogranin A, a protein already studied in cardiovascular research contexts
- Cognitive improvement was measured in spatial memory tasks alongside a reduction in tau burden
- Mouse tau models have a poor translation record to humans; clinical trial confirmation is required